NL-OMON47994已完成不适用
An open-label, multiple oral dose study to investigate the plasma and CSF pharmacokinetics of CAD-1883 in healthy volunteers - Oral dose of CAD-1883
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Subject is male or female of non-childbearing potential, aged between 50 and 65
- •years (inclusive).
- •BMI of *18.0 kg/m2 and * 30.0 kg/m2 at Screening.
- •Healthy as determined by the Investigator, based upon a medical evaluation
- •including medical history, physical examination, neurological examination, lab
- •tests and ECG performed at Screening.
- •Please refer to the protocol for more inclusion criteria
排除标准
- •Prior or ongoing medical condition, medical history, physical findings, ECG
- •findings, laboratory or vital signs abnormality that, in the Investigator*s
- •opinion, could adversely affect the safety of the subject.
- •History of physician diagnosed hereditary ataxia or tremor.
- •History of clinically significant drug allergies.
- •Please refer to the protocol for more exclusion criteria
研究者
相似试验
已完成
1 期
An open-label, multiple oral dose study to explore the pharmacokinetic and pharmacodynamic profiles of 0.5mg colchicine in healthy male adult volunteersCoronary artery diseaseJPRN-UMIN000018042Clinical Trial Center, Kitasato University Hospital8
进行中（未招募）
不适用
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents with Type 2 Diabetes Mellitus.Patients with type 2 diabetes mellitus (T2DM) on a stable dose of Metformin (receiving standard of care)MedDRA version: 16.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2013-005455-32-Outside-EU/EEAJanssen-Cilag International NV16
已完成
不适用
An open label, single oral dose study to investigate the pharamcokinetics - absorption, distribution, metabolism, and elimination - of 75 mg of 14C-labeled BCT197 in healthy male volunteers.NL-OMON36837ovartis4
已完成
1 期
An Ascending Multiple Dose Study of SEP-363856 in Japanese Subjects with SchizophreniaschizophreniaJPRN-jRCT2080223731Sumitomo Dainippon Pharma Co., Ltd.24
进行中（未招募）
不适用
A randomised, open-labelled, multiple dose study of HT61 formulations applied to the anterior nares plus chlorhexidine body and hair washes in subjects with nasal carriage of Staphylococcus aureus - Multiple doses of HT61 formulations in Staph aureus carriersasal carriage of Staphylococcus aureus (including MRSA)MedDRA version: 13Level: LLTClassification code 10067914Term: Staphylococcal colonisationEUCTR2010-021193-11-GBHelperby Thearapeutics Ltd33